EQUITY RESEARCH MEMO

Minnesota Medical Technologies

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)55/100

Minnesota Medical Technologies (MMT) is a privately-held medical device company based in Minneapolis, Minnesota, dedicated to developing innovative continence care solutions. Founded in 2003, the company leverages over 30 years of silicone technology expertise to create products that improve quality of life for individuals with fecal incontinence. Its flagship product, StaySure™, is designed to prevent accidental bowel leakage, offering a proactive alternative to traditional containment devices. MMT operates in the growing continence care market, driven by an aging population and increased awareness of pelvic health issues. While the company has a focused product portfolio and deep domain expertise, it remains a small player in a competitive landscape dominated by larger medical device firms. The company's private status and limited public information suggest a conservative growth trajectory, but its niche product addresses a significant unmet need, positioning it for potential partnership or acquisition opportunities.

Upcoming Catalysts (preview)

  • Q2 2026FDA 510(k) clearance for StaySure next-generation device70% success
  • Q3 2026Strategic distribution partnership with a major healthcare system50% success
  • Q4 2026Publication of clinical outcomes study in peer-reviewed journal60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)